ABT · News · 20260818N

Revenue Performance and Mix

ABBOTT LABORATORIES · 2026-08-18 · Importance 54 · Surprise 40 · No source text

Abbott Laboratories reported second-quarter revenue of $12.59 billion, up 13% year over year. The quarterly result exceeded analyst revenue expectations, according to the third-party reports. The reports also cited quarterly earnings of $1.31 per share, which surpassed analyst estimates.

Key facts

• Abbott Laboratories reported a 13% year-over-year revenue increase to $12.59 billion. source
• Diversified Trust Co. reduced its stake in Abbott Laboratories by 28.6% in the second quarter, selling 26,204 shares and now owning 65,455 shares valued at $5,939,000. source
• Abbott Laboratories reported quarterly revenue of $12.59 billion. source
• Merit Financial Group LLC increased its Abbott Laboratories holdings by 22% in the second quarter to 77,835 shares valued at $7.06 million. source
• Harmony Asset Management LLC purchased 13,560 shares of Abbott Laboratories in the second quarter valued at approximately $1.23 million. source
• Prevail Innovative Wealth Advisors LLC purchased 31,178 shares of Abbott Laboratories in the second quarter valued at approximately $2.83 million. source
• Abbott Laboratories' stock has declined 13.3% over the past year. source
• Abbott Laboratories' stock rose 2.09% to $112.68 on Tuesday, ending a two-day losing streak. source

Impact estimates